Researchers at the University of Toronto have revealed the binding action of the bacterial toxin responsible for toxic shock syndrome. Although similar to the toxin that causes diarrhea, the two proteins behave differently due to a short amino acid sequence, which the researchers were able to manipulate.
Browsing: Bacterial > Clostridium Difficile Infection
Rebiotix (MN, USA) recently announced positive preliminary results from an ongoing clinical trial investigating the use of an investigational microbiota-based formulation, RBX2660, for the reduction of C. diff infection.
Take a look at the industry headlines from the last 2 months, including the FDA approval of Ebola vaccine Ervebo,…
Research has suggested that prophylactic antibiotics are overprescribed before dental visits, and that taking them could actually increase the likelihood of adverse effects.
Research published this week suggests a specific fungus is present in Clostridium difficile infections, potentially presenting a future therapeutic target.
Researchers discover Clostridium difficile is evolving due to genetic changes that allow it to thrive on the Western diet and evade disinfectants making it highly adapted to spread in hospitals.
In a study of healthy infants, researchers discover exposure to C. difficile in infancy may provide natural immunization later in childhood.
Stainless steel and surgical gowns remain contaminated with Clostridium difficile even after treatment with the recommended disinfectant, according to new research.
The US FDA has issued a safety communication regarding investigational FMT, warning that there is a risk of serious infection caused by the transfer of multidrug-resistant organisms.
New research has identified a link between the use of non-steroidal anti-inflammatory drugs – commonly used as pain relief – and more severe C. difficile infections in mouse models.